DE60027455D1 - Oligosaccharidealdonsäure und ihre topische verabreichung - Google Patents

Oligosaccharidealdonsäure und ihre topische verabreichung

Info

Publication number
DE60027455D1
DE60027455D1 DE60027455T DE60027455T DE60027455D1 DE 60027455 D1 DE60027455 D1 DE 60027455D1 DE 60027455 T DE60027455 T DE 60027455T DE 60027455 T DE60027455 T DE 60027455T DE 60027455 D1 DE60027455 D1 DE 60027455D1
Authority
DE
Germany
Prior art keywords
well
prevention
treatment
oral
general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027455T
Other languages
English (en)
Other versions
DE60027455T2 (de
Inventor
Eugene J Van Scott
Ruey J Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60027455D1 publication Critical patent/DE60027455D1/de
Application granted granted Critical
Publication of DE60027455T2 publication Critical patent/DE60027455T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
DE60027455T 1999-06-30 2000-06-28 Oligosaccharidealdonsäure und ihre topische verabreichung Expired - Lifetime DE60027455T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14126499P 1999-06-30 1999-06-30
US141264P 1999-06-30
US487228 2000-01-19
US09/487,228 US6335023B1 (en) 1999-06-30 2000-01-19 Oligosaccharide aldonic acids and their topical use
PCT/US2000/016301 WO2001001932A2 (en) 1999-06-30 2000-06-28 Oligosaccharide aldonic acids and their topical use

Publications (2)

Publication Number Publication Date
DE60027455D1 true DE60027455D1 (de) 2006-05-24
DE60027455T2 DE60027455T2 (de) 2006-12-14

Family

ID=26838940

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027455T Expired - Lifetime DE60027455T2 (de) 1999-06-30 2000-06-28 Oligosaccharidealdonsäure und ihre topische verabreichung

Country Status (16)

Country Link
US (2) US6335023B1 (de)
EP (1) EP1227820B1 (de)
JP (3) JP4326737B2 (de)
CN (1) CN1635864B (de)
AT (1) ATE323498T1 (de)
AU (1) AU775620B2 (de)
BR (1) BRPI0011640B8 (de)
CA (1) CA2373852C (de)
CY (1) CY1105407T1 (de)
DE (1) DE60027455T2 (de)
DK (1) DK1227820T3 (de)
ES (1) ES2262529T3 (de)
HK (1) HK1048764B (de)
MX (1) MX249762B (de)
PT (1) PT1227820E (de)
WO (1) WO2001001932A2 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
FR2775976B1 (fr) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
HUP0300363A2 (hu) * 1999-02-03 2004-06-28 BIOGAL Gyógyszergyár Rt. Eljárás pszeudomonsav A előállítására mikrobiológiai eljárás segítségével
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
DE10114561A1 (de) † 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
WO2003000910A2 (en) * 2001-06-21 2003-01-03 Biogal Gyogyszergyar Rt Metabolic controlled fermentation process for pseudomonic acid production
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
KR20040075857A (ko) * 2001-12-28 2004-08-30 비오갈 기오기스제르갸르 알티. 결정질 및 비결정질 무피로신 칼슘의 제조 방법
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
DE10214507A1 (de) * 2002-04-02 2003-10-16 Beiersdorf Ag Verwendung von Acarbose und deren Derivaten zur Behandlung und Prophylaxe degenerativer Hautzustände
CA2481702A1 (en) * 2002-04-10 2003-10-23 Ruey J. Yu Urea compositions
US7622117B2 (en) * 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
NZ537225A (en) * 2002-05-16 2008-09-26 Sepracor Inc Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20040151716A1 (en) * 2003-02-03 2004-08-05 Hamer Richard A. Material and method for treating microbial mediated dermatological conditions
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
CA2518282C (en) * 2003-03-13 2012-11-06 3M Innovative Properties Company Methods of improving skin quality
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
US7521459B2 (en) * 2003-07-28 2009-04-21 Metabeauty Inc. Method for treating damaged skin
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
DK1641438T3 (da) * 2004-06-01 2010-06-07 Teva Gyogyszergyar Zartkoeruen Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
SG10201404796QA (en) 2004-10-20 2014-10-30 Endorech Inc Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
EP1802278A4 (de) * 2004-10-22 2012-08-01 Dynamis Therapeutics Inc Dermale verabreichung von n-methyl-glucamin- und n-methyl-glucamin-verbindungen
US20060193922A1 (en) * 2005-02-25 2006-08-31 Natalia Neikrug Compositions and methods for the treatment of acne
US7964582B2 (en) * 2005-03-21 2011-06-21 J&J Consumer Companies, Inc. Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers
WO2006130510A2 (en) * 2005-05-27 2006-12-07 Taro Pharmaceuticals U.S.A., Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7709014B2 (en) * 2005-10-17 2010-05-04 Yu Ruey J Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
US20070207222A1 (en) * 2006-03-01 2007-09-06 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080014252A1 (en) * 2006-07-14 2008-01-17 Delprete Keith Topical compositions with long lasting effect
US20080085331A1 (en) * 2006-10-06 2008-04-10 Gluskin Anna E Composition and method for raising blood glucose level
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
WO2009002913A1 (en) * 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2705142A1 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
KR101577471B1 (ko) * 2007-11-16 2015-12-14 알러간, 인코포레이티드 자색반병의 치료를 위한 조성물 및 방법
US10539311B2 (en) * 2008-04-14 2020-01-21 Digital Lumens Incorporated Sensor-based lighting methods, apparatus, and systems
US8823277B2 (en) * 2008-04-14 2014-09-02 Digital Lumens Incorporated Methods, systems, and apparatus for mapping a network of lighting fixtures with light module identification
US8866408B2 (en) * 2008-04-14 2014-10-21 Digital Lumens Incorporated Methods, apparatus, and systems for automatic power adjustment based on energy demand information
US8805550B2 (en) * 2008-04-14 2014-08-12 Digital Lumens Incorporated Power management unit with power source arbitration
US8754589B2 (en) * 2008-04-14 2014-06-17 Digtial Lumens Incorporated Power management unit with temperature protection
WO2009129525A2 (en) * 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
EP2273974A2 (de) * 2008-05-09 2011-01-19 Tolmar, Inc. Proguanil zur behandlung von haut-/schleimhauterkrankungen
US20110098246A1 (en) * 2008-06-06 2011-04-28 N.V. Nutricia Method for preventing corticosteroid usage
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
CA2746425C (en) * 2008-12-10 2016-05-03 Allergan, Inc. Clostridial toxin pharmaceutical compositions
WO2010083239A2 (en) * 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication
US8954170B2 (en) * 2009-04-14 2015-02-10 Digital Lumens Incorporated Power management unit with multi-input arbitration
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
US20120027876A1 (en) * 2010-07-27 2012-02-02 Sara Beth Ford Composition and Method for the Topical Treatment of Dermatitis
JP6057496B2 (ja) * 2010-12-24 2017-01-11 サンエイ糖化株式会社 歯牙エナメル質の再石灰化促進剤
WO2012177433A1 (en) * 2011-06-21 2012-12-27 Evologie Llc Topical compositions for the treatment of dermatological disorders
JP6222894B2 (ja) * 2012-03-30 2017-11-01 小林製薬株式会社 表皮肥厚促進剤
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US9089506B2 (en) * 2013-02-27 2015-07-28 Precision Dermatology, Inc. Stable, non-irritating topical formulations of hydroquinone
EP3035908B1 (de) 2013-08-15 2019-05-29 Mary Kay, Inc. Topische zusammensetzungen für die haut zur behandlung von falten
JP6305727B2 (ja) * 2013-10-31 2018-04-04 ポーラ化成工業株式会社 皮膚光老化防止用組成物
JP6580342B2 (ja) * 2014-02-28 2019-09-25 マルホ株式会社 トロポエラスチン発現促進剤およびエラスチン産生促進剤
AU2014392694B2 (en) 2014-04-30 2020-07-02 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging
WO2015167535A1 (en) * 2014-04-30 2015-11-05 Kimberly-Clark Worldwide, Inc. Methods of reducing signs of skin aging using a combination of extracts
US11154491B2 (en) 2014-04-30 2021-10-26 Kimberly-Clark Worldwide, Inc. Use of Undaria extract to reduce signs of skin aging
AU2014392689B2 (en) 2014-04-30 2020-12-17 Kimberly-Clark Worldwide, Inc. Compositions and methods for reducing oxidative stress
WO2015167557A1 (en) 2014-04-30 2015-11-05 Kimberly-Clark Worldwide, Inc. Topical compositions for stimulating adipogenesis and lipogenesis to reduce the signs of skin aging
US10123964B2 (en) 2014-04-30 2018-11-13 Kimberly-Clark Worldwide, Inc. Topical composition including a combination of extracts for reducing signs of skin aging
WO2016105499A1 (en) 2014-12-23 2016-06-30 Intellectual Property Associates, Llc Methods and formulations for transdermal administration
JP2015221821A (ja) * 2015-08-11 2015-12-10 サンエイ糖化株式会社 歯牙エナメル質の再石灰化促進剤
KR102406880B1 (ko) 2015-10-30 2022-06-08 팀버 파마슈티칼스 엘엘씨 이소트레티노인 제형 및 이의 용도 및 사용 방법
CN105853275B (zh) * 2016-04-26 2018-10-02 上海波林丝生物科技有限公司 一种生发育发的自然植物组分的配方
GB2562270B (en) 2017-05-10 2020-07-01 Hyphens Pharma Pte Ltd Skin barrier composition
US10556133B2 (en) 2017-06-05 2020-02-11 Momentive Performance Materials Inc. Composition and method for strengthening hair fiber
WO2019055880A2 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. METHOD OF ADMINISTRATION AND TREATMENT
CN111867568A (zh) 2018-01-18 2020-10-30 C·阿尔诺德 包含聚已缩胍的口香糖组合物
KR102199678B1 (ko) * 2018-08-23 2021-01-07 주식회사 엘지생활건강 인간지방줄기세포의 분화 촉진용 조성물
CN111514161B (zh) * 2020-05-28 2021-05-04 江苏雪豹日化有限公司 一种抗口腔溃疡制剂及其应用
CN111690072B (zh) * 2020-06-05 2021-05-28 江南大学 一种棉织物用多醛酸抗皱整理剂的制备及其应用
KR102598193B1 (ko) * 2021-06-14 2023-11-06 대상 주식회사 효소적 산화를 이용한 말토비온산 제조방법
AU2021461617A1 (en) * 2021-08-23 2024-02-08 The Procter & Gamble Company Oral care compositions for gum health
CA3229228A1 (en) * 2021-08-23 2023-03-02 The Procter & Gamble Company Oral care compositions for gum health

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1772975A (en) 1925-06-20 1930-08-12 Firm C H Boehringer Sohn Chem Process for the production of antiseptic agents
US2118566A (en) 1935-08-29 1938-05-24 Miles Gilbert De Wayne Buffered cosmetic
US3227616A (en) 1961-07-03 1966-01-04 Warner Lambert Pharmaceutical Emulsions of cactus plant extract
US3689668A (en) 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
SE325667B (de) 1968-03-06 1970-07-06 Medisan Ab
GB1316971A (en) 1969-05-20 1973-05-16 Hayashibara Co Process for production of aldobionic acids and their salts
FR2072692A5 (de) 1969-12-04 1971-09-24 Hayashibara Co
GB1388836A (en) 1971-06-01 1975-03-26 Medisan Ab Cosmetic compositions
US3879537A (en) 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3991184A (en) 1973-10-05 1976-11-09 Martin Kludas Agent for the care of skin
US4294852A (en) 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US3984566A (en) 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
US3988470A (en) 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
ZA752066B (en) 1974-05-02 1976-03-31 Draco Ab Dermatologically active preparation
US4197316A (en) 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4380549A (en) 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4021572A (en) 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4363815A (en) 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4053630A (en) 1976-07-07 1977-10-11 Yu Ruey J Treatment of body odor and disturbed keratinization
BR7904612A (pt) 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
US4234599A (en) 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4287214A (en) 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
PH18373A (en) 1982-02-02 1985-06-13 Unilever Nv Skin treatment composition
US4518789A (en) 1982-06-30 1985-05-21 Yu Ruey J Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use
DE3239296A1 (de) * 1982-10-23 1984-06-14 Henkel Kgaa Haarkosmetische mittel
US4608370A (en) 1985-03-04 1986-08-26 Aronsohn Richard B Skin formulation
DE3540175C2 (de) 1985-11-13 1997-03-27 Merck Patent Gmbh Dithranolhaltige pharmazeutische Zubereitung
US4929722A (en) 1986-06-06 1990-05-29 Union Carbide Chemicals And Plastics Company Inc. Acid decrystallization of aminopolysaccharides and derivatives thereof
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5547988B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US4983382A (en) 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
US5021451A (en) 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
GB9003201D0 (en) 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
US5093109A (en) 1990-04-04 1992-03-03 Chanel, Inc. Cosmetic composition
US5290766A (en) 1991-02-18 1994-03-01 The National Heart Foundation Of New Zealand Cardioplegic compositions
DE69228622T2 (de) * 1991-04-10 1999-12-02 Eugene J Van Scott Verwendung von 2-Hydroxycarbonsäure oder deren Derivaten enthaltende Zusammensetzung zur Linderung von Wechseln Nagelveränderungen
FR2681863B1 (fr) 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
JP3082058B2 (ja) * 1992-05-22 2000-08-28 株式会社ホーネンコーポレーション ６−Ｏ−α−Ｄ−ガラクトピラノシル−Ｌ−アスコルビン酸またはその塩およびその製造法並びにその用途
JPH06263790A (ja) * 1993-03-12 1994-09-20 Unitika Ltd ２−Ｏ−β−Ｄ−ガラクトピラノシル−Ｌ−アスコルビン酸またはその塩およびその製造法並びにその用途
US5714163A (en) 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
JPH08291192A (ja) * 1995-04-25 1996-11-05 Nippon Shokuhin Kako Co Ltd ラクトン化オリゴ糖、その製造方法及びα−アミラーゼ阻害剤
US5877212A (en) 1997-04-16 1999-03-02 Yu; Ruey J. Molecular complex and control-release of alpha hydroxyacids
US6159480A (en) * 1997-12-15 2000-12-12 Neostrata Company, Inc. Cosmetic makeup composition
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use

Also Published As

Publication number Publication date
AU775620B2 (en) 2004-08-05
CY1105407T1 (el) 2010-04-28
DK1227820T3 (da) 2006-08-21
ES2262529T3 (es) 2006-12-01
HK1048764A1 (en) 2003-04-17
JP2005232180A (ja) 2005-09-02
BR0011640A (pt) 2002-05-14
CN1635864B (zh) 2010-06-16
JP4326737B2 (ja) 2009-09-09
EP1227820B1 (de) 2006-04-19
MX249762B (es) 2007-10-01
CN1635864A (zh) 2005-07-06
US20020028227A1 (en) 2002-03-07
US6335023B1 (en) 2002-01-01
JP4804018B2 (ja) 2011-10-26
CA2373852A1 (en) 2001-01-11
ATE323498T1 (de) 2006-05-15
HK1048764B (zh) 2006-09-15
BRPI0011640B8 (pt) 2021-05-25
WO2001001932A3 (en) 2001-05-17
EP1227820A2 (de) 2002-08-07
JP2003503436A (ja) 2003-01-28
US6740327B2 (en) 2004-05-25
MXPA01013042A (es) 2003-08-20
CA2373852C (en) 2009-06-23
WO2001001932A2 (en) 2001-01-11
BR0011640B1 (pt) 2014-07-29
PT1227820E (pt) 2006-08-31
JP2011140499A (ja) 2011-07-21
AU6335300A (en) 2001-01-22
DE60027455T2 (de) 2006-12-14

Similar Documents

Publication Publication Date Title
DE60027455D1 (de) Oligosaccharidealdonsäure und ihre topische verabreichung
DE60027463D1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
JP6239041B2 (ja) 微生物感染の治療に使用するためのタマリンド種子多糖
NO20044699L (no) Vaginalpleiesammensetning
ITFI20080035A1 (it) Composizione odontoiatrica per la prevenzione ed il trattamento della stomatite e delle ulcerazoni della mucosa orale
PT1326613E (pt) Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
MX2009004980A (es) Composiciones topicas que comprenden polihidroxi acidos y/o lactonas para efectos cutaneos mejorados de farmacos terapeuticos oxidantes.
EP1444984B1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
JP2010502601A5 (de)
JP5981419B2 (ja) 炎症性疾患の治療に使用するためのタマリンド種子多糖
DE69927497D1 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklylamidverbindungen
WO2014095489A1 (en) Topical oral composition for alleviating dry mouth symptoms and for treating mouth ulcers
DE50213137D1 (de) Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
NO20006260L (no) Farmasöytisk sammensetning på basisen av erytromycin- fettsyresalter til topisk behandling av hudsykdommer
SHARMA REVIEWING DANTA GATA (DENTAL) VISHA CHIKITSA IN PRESENT DAY ORO-DENTAL DISEASES-AN AYURVEDA CONCEPT
BR0206336A (pt) Processo de preparação de composições farmacêuticas de antimicrobianos, anestésicos, antifúngicos e antinflamatórios para liberação lenta e produtos derivados
DE60035351D1 (de) Topische behandlung von autoimmunerkrankungen der mundhöhle durch azathioprin
JP2003183170A (ja) うがい剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition